Study in HCV-Infected Patients to Determine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of JNJ-47910382

NCT01651767 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class

Stopped Because of many competing trials using the same mechanism of action, but being further advanced in development

Conditions

Interventions

Sponsor

Janssen R&D Ireland